FAM133B and nasopharyngeal carcinoma: All these results suggested that the lncRNA FAM133B-2 might function as a competitive endogenous RNA (ceRNA) for miR-34a-5p in NPC radio-resistance, thus it may represent a feasible biomarker for diagnosis and treatment of NPC radio-resistance.